Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

被引:50
作者
Hanefeld, Markolf [1 ]
Koehler, Carsta [1 ]
Gallo, Silvina [1 ]
Benke, Inge [1 ]
Ott, Petra [1 ]
机构
[1] Tech Univ Dresden, Ctr Clin Studies Metab & Endocrinol, D-01307 Dresden, Germany
关键词
D O I
10.1186/1475-2840-6-13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One of the major controversies surrounding the metabolic syndrome (MetS) in type 2 diabetes is whether its single components act synergistically as risk factors for atherosclerotic vascular disease (AVD). We aimed to answer this by evaluating the relationship, and its various combinations to AVD in comparison to single traits in a population-based study with type 2 diabetes in Germany. Methods and results: 4020 unselected patients with type 2 diabetes aged 35-80 years. MetS was: diabetes plus >= 2 traits of the MetS by AHA/NHBLI definition. AVD was: history of myocardial infarction and/or coronary revascularization and/or stroke. The occurrence of AVD in relation to overall MetS/single traits/combinations was presented as OR (95% Cl). Multiple logistic regression, including established cardiovascular risk factors, modeled their associations. The prevalence of overall MetS was 74.4% and the OR for AVD was 1.41 (1.12-1.78), which however was higher for hypertension as single trait ( OR 4.76). Different combinations of MetS presented a wide range of ORs (0.47 to 10.90) and strong sex differences. Some clusters of MetS including hypertension and low HDL-cholesterol presented a higher risk factor than single traits or their sum, whereas the others out of 11 possible carried no increased AVD risk. Multiple logistic regression showed independent association between AVD and overall MetS. Conclusion: The overall MetS in type 2 diabetes comprises 11 heterogenous clusters of traits. Overall MetS increases the risk of AVD in type 2 diabetes and individual traits in some clusters with hypertension and low HDL-cholesterol may act synergistically as risk factors particularly in women.
引用
收藏
页数:7
相关论文
共 17 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]   The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study [J].
Bonora, E ;
Targher, G ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Gemma, L ;
Santi, L ;
Bonadonna, RC ;
Muggeo, M .
DIABETIC MEDICINE, 2004, 21 (01) :52-58
[3]   Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 3 diabetes [J].
Bruno, G ;
Merletti, F ;
Biggeri, A ;
Bargero, G ;
Ferrero, S ;
Runzo, C ;
Cerai, SP ;
Pagano, G ;
Cavallo-Perin, P .
DIABETES CARE, 2004, 27 (11) :2689-2694
[4]   Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes [J].
Costa, LA ;
Canani, LH ;
Lisbôa, HRK ;
Tres, GS ;
Gross, JL .
DIABETIC MEDICINE, 2004, 21 (03) :252-255
[5]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[6]   Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes [J].
Guzder, RN ;
Gatling, W ;
Mullee, MA ;
Byrne, CD .
DIABETOLOGIA, 2006, 49 (01) :49-55
[7]  
HANEFELD M, 1981, DEUT GESUNDHEITSWES, V36, P545
[8]   Increased mortality associated with the metabolic syndrome in older women with diabetes [J].
Hillier, TA ;
Rizzo, JH ;
Pedula, KL ;
Cauley, JA ;
Schwartz, AV ;
Ensrud, KE ;
Browner, WS .
DIABETES CARE, 2005, 28 (09) :2258-2260
[9]   Prevalence of the metabolic syndrome and its components -: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort [J].
Ilanne-Parikka, P ;
Eriksson, JG ;
Lindström, J ;
Hämäläinen, H ;
Keinänen-Kiukaanniemi, S ;
Laakso, M ;
Loutheranta, A ;
Mannelin, M ;
Rastas, M ;
Salminen, V ;
Aunola, S ;
Sundvall, J ;
Valle, T ;
Lahtela, J ;
Uusitupa, M ;
Tuomilehto, J .
DIABETES CARE, 2004, 27 (09) :2135-2140
[10]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689